The enhanced expression level of COMP in tumor cells is significantly related to the reduced breast cancer-specific survival rate and recurrence-free survival rate of patients, while the expression level of COMP in the stroma has a poor connection with prognosis (Englund et al., 2016). The gene discussed is COMP; the disease is breast carcinoma.